Cancer and inflammation: implications for pharmacology and therapeutics.
about
Regulation of inflammation in cancer by eicosanoidsDelivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancerLong-term safety and efficacy of infliximab for the treatment of ankylosing spondylitisTargeted therapy for hepatocellular carcinoma: novel agents on the horizonEET signaling in cancerA multi-targeted approach to suppress tumor-promoting inflammationInflammation and skeletal metastasisInflammation meets cancer, with NF-κB as the matchmakerThe inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells.Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism.Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling.Association between macrophage migration inhibitory factor promoter region polymorphism (-173 G/C) and cancer: a meta-analysisSmall interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer modelCellular phenotype-dependent and -independent effects of vitamin C on the renewal and gene expression of mouse embryonic fibroblastsSystemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancerOral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trialMolecular biology for formyl peptide receptors in human diseases.In vivo inhibition of c-MYC in myeloid cells impairs tumor-associated macrophage maturation and pro-tumoral activities.The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role.Breast cancer metastasis to the bone: mechanisms of bone lossThe first Tianjin, China forum on tumor microenvironment.Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.Tumor necrosis factor inhibitors - state of knowledge.Complications following liver resection for colorectal metastases do not impact on longterm outcomeInterplay between DNA repair and inflammation, and the link to cancerIdentification of gene expression changes from colitis to CRC in the mouse CAC modelThe Mushroom Agaricus blazei Murill Elicits Medicinal Effects on Tumor, Infection, Allergy, and Inflammation through Its Modulation of Innate Immunity and Amelioration of Th1/Th2 Imbalance and InflammationRegulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathwayPrognostic value of neutrophil-to-lymphocyte ratio in breast cancer.Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer.Rethinking ovarian cancer: recommendations for improving outcomes.Biomarkers in Exhaled Breath Condensate and Serum of Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer.Identification of a genetic locus controlling bacteria-driven colitis and associated cancer through effects on innate inflammationPGE2 promotes renal carcinoma cell invasion through activated RalA.Development and External Validation of Nomograms for Predicting Survival in Nasopharyngeal Carcinoma Patients after Definitive Radiotherapy.Association of Tartrate-Resistant Acid Phosphatase-Expressed Macrophages and Metastatic Breast Cancer Progression.Transgenic expression of interferon-γ in mouse stomach leads to inflammation, metaplasia, and dysplasiaThe combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancerMicrobial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease?An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in mice
P2860
Q24564308-CFE1B3F8-C9F5-4815-90A7-31465EA148E7Q24614491-104AD720-51DD-4DC8-BF4D-43065FB9EFBFQ26774173-EE06548B-854F-4F09-888F-108474A12FF9Q27002288-C4BEE1A6-B3FD-4D66-B903-A6985AD04EDCQ28250730-A1FC054F-AE7F-4591-A307-246BF3846DF7Q28393278-58977DBF-71E3-4D65-828D-7D0C7EA32392Q28396089-7D4DB199-DA1F-454F-8CEA-5A82D9DFFA00Q29620242-D7937502-E339-4EF5-BBB3-FD4D6D8CB1E2Q33587770-F337C2CE-1CA8-4C1B-B767-A9B69C82EAB9Q33887570-09E708F6-AB2D-42AE-AB7B-C39C38D3C440Q33982374-99485913-E92C-43EC-8848-7B82EDD45E3AQ34100932-C8C6EBD7-1DAF-4EA0-A872-D2D7B3CF27DAQ34123598-235F93D4-77CC-4285-8E25-2E1CCBE8A93CQ34200211-0066D0BC-2CF0-4047-B07B-326A9C0FD69BQ34215504-F3975765-0008-4F23-AA06-05577FF8A70FQ34222648-02039678-7174-4CD9-ACCF-05B7D942681FQ34327503-552759A3-CE16-4D61-886A-C3BB079AB20DQ34428953-658E3A9C-2A1D-4B26-AD93-7EC6B7F4AC4DQ34547396-82AE6B2F-A941-4191-AA23-342CDB886B2EQ34613578-279A5AE4-BEB1-4E9F-B808-01A4246F7507Q34786304-B8314E54-AF2E-4E6F-817A-1B275F91DCFDQ34806672-527E3D9E-7A75-4107-A2AB-6E5860A3D250Q34974335-69E72DC2-0DC1-4E8A-82D1-356CF37E83F9Q34986203-917BD958-2A02-4574-BE4A-BAAB8BA1FCE7Q34989590-3F42C0BF-C56B-4377-A882-48725C7BEC6CQ35151772-3E7A5091-B103-435A-AAFC-284BB80C178EQ35200192-FA545EA1-2ADB-44DC-8B8F-238D537DE402Q35748219-926DE89E-993B-4A06-AD5B-C895E5CEC431Q35790197-BBAB4683-49A8-456E-998C-0440D4235B79Q35897669-9EA83E91-33E3-4551-B76C-514658AAE502Q36050883-769DF687-86FA-48A9-A156-19E1BEBCE11FQ36112558-21AB9353-522C-487B-9625-7152DF144257Q36118315-DDCBBC5F-7193-46D1-A069-23C7E6266105Q36170200-00C2A36D-2E0A-4864-B6DA-E0FD9F2B0A39Q36205922-57196987-05BD-4F85-8812-97F4FB698909Q36359105-71B20D48-6938-4929-B830-5D56A76F928BQ36433023-44C30036-CD1C-4EAA-B57F-628E99AEB8E4Q36499781-0B75B868-39E8-4E1B-8ABF-AB8113CD7814Q36761864-D36345F8-6139-476B-AB15-7974CFDD89E7Q36796828-FEE3E40C-338C-44B2-8ACC-2931C89B9B03
P2860
Cancer and inflammation: implications for pharmacology and therapeutics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cancer and inflammation: implications for pharmacology and therapeutics.
@en
Cancer and inflammation: implications for pharmacology and therapeutics.
@nl
type
label
Cancer and inflammation: implications for pharmacology and therapeutics.
@en
Cancer and inflammation: implications for pharmacology and therapeutics.
@nl
prefLabel
Cancer and inflammation: implications for pharmacology and therapeutics.
@en
Cancer and inflammation: implications for pharmacology and therapeutics.
@nl
P2860
P356
P1476
Cancer and inflammation: implications for pharmacology and therapeutics.
@en
P2860
P304
P356
10.1038/CLPT.2009.312
P407
P577
2010-03-03T00:00:00Z